FERMENTA vs SYMBIOTEC: Stock Comparison
SYMBIOTEC PHARMALAB is the larger company by market capitalisation. FERMENTA BIOTECH shows a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
FERMENTA leads 2; SYMBIOTEC leads 0 of 4
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | FERMENTA | SYMBIOTEC |
|---|---|---|
| Live Price | ₹468 | ₹1,036 |
| Day Change | -0.43% | -0.65% |
| Volume | 21,925 | 2.72 L |
| 52-Week High | ₹580.45 | ₹1,193.7 |
| 52-Week Low | ₹248.85 | ₹934.2 |
| Distance from 52W High | -19.37% | -13.21% |
Valuation
| Metric | FERMENTA | SYMBIOTEC |
|---|---|---|
| Market Cap | ₹1,360 Cr | ₹6,624 Cr |
| P/E Ratio | 23.18x | — |
| P/B Ratio | 3.42x | — |
| EPS | ₹5.09 | — |
| Book Value | ₹136.1 | — |
| Dividend Yield | 0.79% | 0% |
Growth
| Metric | FERMENTA | SYMBIOTEC |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | -8.19% | — |
| Qtr Profit Growth | 57.22% | — |
Profitability & Leverage
| Metric | FERMENTA | SYMBIOTEC |
|---|---|---|
| ROE | 15.2% | — |
| ROCE | 14.25% | — |
| Net Margin | 13.37% | 0% |
| Operating Margin | 22.37% | — |
| Debt to Equity | 0.26x | — |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | FERMENTA | SYMBIOTEC |
|---|---|---|
| Promoter Holding | 56.47% | 33.28% |
| FII Holding | 0.13%▲ 0.11 pp | 21.08% |
| DII Holding | 0.04%▲ 0.04 pp | 27.52% |
| Public Holding | 33.2%▼ 0.1 pp | 18.12% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FERMENTA BIOTECH and SYMBIOTEC PHARMALAB.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.